1. Morrish NJ, Wang SI, Stevens LK, Fuller JH, Keen H: WHO Multinational Study Group: Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetalogia 44: S14–S21, 2001
2. Mohan V, Premalatha G, Sastry NG: Ischaemic heart disease in south Indian NIDDM patients-A clinic based study on 6597 NIDDM patients. Int J Diab Dev Countries 15: 64–67, 1995
3. Goodman LS, Gilman A: The pharmacological basis of therapeutics, 10th ed. (McGraw-Hill, New York, 2001)
4. Fox KM, Henderson JR, Bertrand ME, et al.: The European trial on reduction of cardiac events with perindoril in stable coronary artery disease (EUROPA). Eur Heart J 19: J52–J55, 1998
5. Schernthaner G: Gliclazide modified release: A critical review of pharmacodynamic, metabolic and vasoprotective effects. Metabolism 52: 29–34, 2003